Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis

The number of ageing people with relapsing multiple sclerosis (RMS) is increasing. The efficacy of disease-modifying therapies (DMTs) for RMS declines with age. Also, older persons with MS may be more susceptible to infections, hospitalisations and malignancy. Aging people with MS have higher rates...

Full description

Bibliographic Details

Published in:	Neurology and therapy Vol. 13; no. 3; pp. 519 - 533
Main Authors:	de Seze, Jerome, Dive, Dominique, Ayrignac, Xavier, Castelnovo, Giovanni, Payet, Marianne, Rayah, Amel, Gobbi, Claudio, Vermersch, Patrick, Zecca, Chiara
Format:	Journal Article
Language:	English
Published:	Cheshire Springer Healthcare 01.06.2024 Adis, Springer Healthcare
Series:	Neurology and Therapy
Subjects:	Ageing Cladribine tablets Disease-modifying therapy Internal Medicine Life Sciences Medicine Medicine & Public Health Neurology Relapsing multiple sclerosis Review Relapsing multiple sclerosis Cladribine tablets Disease-modifying therapy Ageing
ISSN:	2193-8253, 2193-6536
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!